Pre-IND and Distribution Strategies - Ensuring Efficient Clinical Studies

Navigating the complexities of early-phase clinical trials requires strategic foresight and regulatory expertise. 

Hear from our industry experts, Sharlett Burgess and Zach Rupert, as they share invaluable insights on:

• Pre-IND Strategy & Regulatory Considerations – How proactive planning can reduce First Patient-In (FPI) timelines by 6-8 weeks and streamline the IND submission process.
• Leveraging a Canadian CDMO – Understanding the benefits of importing, labeling, and packaging clinical trial materials in Canada to enable immediate shipment post-IND approval.
• Global Depot & Distribution Strategies – Overcoming supply chain complexities with a tailored approach for different regulatory environments worldwide.
• Risk Mitigation & Compliance – Addressing potential challenges in Pre-IND packaging, import/export logistics, and evolving global trade & tariff regulations.

This webinar will help you enhance your clinical supply strategy, reduce regulatory bottlenecks, and ensure seamless distribution of investigational medicinal products.